ECLectic: The electrochemiluminescence (ECL) doctoral network for early sepsis diagnosis will form the next generation of clinically oriented analytical scientists capable of delivering innovative solutions that will improve the lives of patients, reduce the cost of healthcare and position Europe as a leader in biomedical devices. We have selected sepsis as the target disease because it is a significant analytical challenge, demanding extreme detection sensitivity, high selectivity and extremely rapid response. ECL is a powerful diagnostics tool with exceptional performance in terms of signal to noise ratio. To reach these goals, we have assembled a highly inter- and multidisciplinary and cross-sectoral eclectic team of analytical scientists, (nano)(bio) materials specialists, microfluidic device engineers as well as clinicians so as to enable ultimate translation to the clinic.


European Community HORIZON-MSCA-2022-DN-01 - MSCA Doctoral Networks 2022

02/2024 - 01/2028